Some argue that Trump is simply using threats of injurious trade penalties in order to win smaller, different concessions. Others see a far more dramatic agenda at play.

Can the U.S. pharmaceutical supply chain come home — or, at least, get closer to it?

Although Trump has repeatedly said he wants the U.S. to retake the Panama Canal, his actual goals could fall well short of that. 

Leaders announced the reintroduction of the Railway Safety Act, which was first proposed in Congress the month after the derailment in 2023, but died in committee months later.

Shippers are holding their collective breath to see how a rash of uncertainties surrounding the U.S. and global economies will impact freight rates in 2025.

The future contains much uncertainty, but also a wealth of opportunities for innovative and far-thinking enterprises. 

The very conditions that allow U.S. egg farmers to pump out tens of billions of eggs a year are also what make flocks so susceptible to disease in the first place.

Businesses that can reinvent or reinvigorate their operations stand the best chance of driving new competitive advantage from ongoing tariff volatility.

In supply chain, all the talk today is about AI-driven autonomous operations, removing the need for human intervention in key decision-making.

Of all the many links that make up a global supply chain, drayage is among the most challenging to perform efficiently and profitably.